CLINICAL TRIALS PROFILE FOR COLCHICINE
✉ Email this page to a colleague
All Clinical Trials for COLCHICINE
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00000577 ↗ | Asthma Clinical Research Network (ACRN) | Withdrawn | National Heart, Lung, and Blood Institute (NHLBI) | Phase 3 | 1993-09-01 | This study will establish a network of interactive asthma clinical research groups to evaluate current therapies, new therapies, and management strategies for adult asthma. |
| NCT00000577 ↗ | Asthma Clinical Research Network (ACRN) | Withdrawn | Milton S. Hershey Medical Center | Phase 3 | 1993-09-01 | This study will establish a network of interactive asthma clinical research groups to evaluate current therapies, new therapies, and management strategies for adult asthma. |
| NCT00004368 ↗ | Phase I Study of Colchicine Therapy in Childhood Hepatic Cirrhosis | Unknown status | Children's Hospital Colorado | Phase 1 | 1990-05-01 | OBJECTIVES: I. Investigate the efficacy and safety of colchicine therapy in improving hepatic function and reducing hepatic fibrosis (scarring) in children with hepatic cirrhosis. |
| NCT00004368 ↗ | Phase I Study of Colchicine Therapy in Childhood Hepatic Cirrhosis | Unknown status | National Center for Research Resources (NCRR) | Phase 1 | 1990-05-01 | OBJECTIVES: I. Investigate the efficacy and safety of colchicine therapy in improving hepatic function and reducing hepatic fibrosis (scarring) in children with hepatic cirrhosis. |
| NCT00004748 ↗ | Low-Dose Oral Methotrexate Versus Colchicine for Primary Biliary Cirrhosis | Completed | Tufts Medical Center | Phase 3 | 1989-11-01 | OBJECTIVES: I. Compare the efficacy of low-dose oral pulse methotrexate (MTX) and ursodiol versus colchicine and ursodiol in patients with primary biliary cirrhosis (PBC). II. Determine the optimum dose and duration of MTX treatment. III. Investigate the role of fibrogenic cytokines (FC) in PBC pathogenesis and the effect of treatment on FC production. |
| NCT00004748 ↗ | Low-Dose Oral Methotrexate Versus Colchicine for Primary Biliary Cirrhosis | Completed | National Center for Research Resources (NCRR) | Phase 3 | 1989-11-01 | OBJECTIVES: I. Compare the efficacy of low-dose oral pulse methotrexate (MTX) and ursodiol versus colchicine and ursodiol in patients with primary biliary cirrhosis (PBC). II. Determine the optimum dose and duration of MTX treatment. III. Investigate the role of fibrogenic cytokines (FC) in PBC pathogenesis and the effect of treatment on FC production. |
| NCT00047489 ↗ | Study of ABT-751 in Patients With Refractory Hematologic Malignancies | Completed | M.D. Anderson Cancer Center | Phase 1 | 2002-12-01 | ABT-751 is a new antitumor drug that that interferes with cell division. The goal of this clinical research study is to find the highest safe dose of ABT-751 that can be given as a treatment for refractory hematologic malignancies. The safety and side effects of ABT-751 will also be studied. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for COLCHICINE
Condition Name
Clinical Trial Locations for COLCHICINE
Trials by Country
Clinical Trial Progress for COLCHICINE
Clinical Trial Phase
Clinical Trial Sponsors for COLCHICINE
Sponsor Name
